Clinical Trial

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional near-infrared spectroscopy (fNIRS). By comparing brain activity across different groups and relating it to symptom severity, this study aims to improve our understanding of how these conditions affect the brain.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-20; most recent amendment 2026-04-24.
Trial Details
NCT Number NCT06897670
Lead Sponsor Mayo Clinic
Conditions Major Depressive Disorder, Bipolar Disorder, Mild Cognitive Impairment
Enrollment 200 participants
Start Date 2025-03-26
Primary Completion 2028-03-30 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-29